Monitoring brain tumors during systemic treatment
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether it's safe to skip radiation and instead rely on a new systemic treatment (like immunotherapy or targeted therapy) to control brain tumors that have spread from other parts of the body. It might help you manage your disease while avoiding the side effects of radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with cancer that has spread to the brain (brain metastasis) and have at least one new or growing tumor in the brain that hasn't been treated before.
- You do not have symptoms caused by the brain tumors, and you are not needing steroids or seizure medication due to the brain tumors.
- The largest brain tumor is smaller than 3 centimeters (about 1.2 inches).
- You plan to start a new type of systemic treatment (medicine that travels through the body) that is expected to work in the brain, and you haven't had this exact treatment before.
- You are willing to delay radiation therapy and to undergo regular MRI scans and complete questionnaire-based assessments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a precise type of radiation to the brain and spine (craniospinal irradiation) can help control cancer that has spread to the lining of the brain and spinal cord (leptomeningeal disease) in people with breast cancer or non-small cell lung cancer. The goal is to improve symptoms and slow disease progression.
This study is for people with melanoma or lung cancer that has spread to the brain and who have had surgery to remove the brain tumor. It looks at whether it is safe to skip the usual radiation treatment after surgery, while taking a targeted drug therapy that is known to be effective in the brain.
This trial tests whether some people with brain metastases from solid tumors can safely skip radiation if their cancer drugs (like targeted therapy, immunotherapy, or certain chemotherapies) shrink the brain tumors. You will get MRI scans to see if the drugs are working.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This trial looks at whether the timing of radiation therapy and immunotherapy (like Keytruda or Opdivo) affects outcomes in patients with non-small cell lung cancer (NSCLC) that has spread to the brain. You would receive both treatments as part of your normal care, and the study will track how you do.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
Hear when a new Brain Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.